Tuesday, November 12, 2013

Qualtiy Systems (QSII) 2013 Review

Quality Systems Inc develops and markets healthcare information systems in the US; they include systems that automate medical and dental practices and networks of practices such as physician hospital and management services organizations, ambulatory care centers and medical and dental schools.  In addition, QSII offers proprietary electronic medical records under the NextGen product name.  Its products include electronic health records, enterprise appointment scheduling, enterprise master patient index, NextGen image control systems, managed care server, electronic data interchange, system interfaces, Internet operability and patient-centric and provider-centric Wed portal solutions, NextGen Express for small practices, revenue cycle management services which include billing and collections services.  The company has grown profits at a 25% rate over the past ten though dividends have advanced at only a 7% pace.  Return on equity has been in the 15-20% range.

The company witnessed a slowdown in profit growth as ambiguity in the regulatory environment dampened sales; however, as clarity is gained once the election is over, it should resume growth at an above average pace as a result of:

(1) expansion of its client base, its product offerings and the rising demand of its clients for its expertise,

(2) strong demand in its NextGen division,

(2) acquisitions.

Negatives:

(1) it is in a highly competitive industry,

(2) its business is overly concentrated in physician practice,

(3) weakness in the software environment.

QSII is rated B++ by Value Line, has no debt and its stock yields 3.3%

      Statistical Summary

                 Stock      Dividend         Payout      # Increases  
                Yield      Growth Rate     Ratio       Since 2005

QSII          3.3%           7%               58%             6*
Ind Ave      3.5              7**              61               NA 

                Debt/                      EPS Down       Net        Value Line
               Equity         ROE      Since 2003      Margin       Rating

QSII          0%             21%            0                14%           B++
Ind Ave     26              13              NA                8             NA

* QSII has only paid a dividend for 9 years
**most companies in QSII industry do not pay dividends

     Chart
           
            Note: QSII made great initial progress off its March 2009 low, quickly surpassing the downtrend off its September 2008 high (red line) and the November 2008 trading high (green line).  Long term the stock is in a trading range (straight blue lines).  Intermediate term, it is in an uptrend (purple lines).  The wiggly blue line is on balance volume.  The Aggressive Growth Portfolio owns a one half position in QSII---and got there by a circuitous route.  In 2012, it owned full position.  In mid 2012, the stock broke below its Stop Loss Price.  Our Portfolio Sold about half the position---my strategy being to average out which was clearly a mistake.  But as you can see, it broke down badly on one day, leaving me with the decision to Sell at a huge discount or wait for a rebound.  I chose the latter and our Portfolio Bought some shares back in late 2012.  The upper boundary of its Buy Value Range is $20; the lower boundary of its Sell Half Range is $77. 




11/13

No comments:

Post a Comment